8-K Filing

Company

Vistagen Therapeutics, Inc.

Filed

February 11, 2016

Period of Report

February 10, 2016

Accession Number

0001415889-16-004728

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →